Ji-Won Kim
Chief Executive Officer at AJU IB INVESTMENT CO., LTD.
Net worth: 272 166 $ as of 30/04/2024
Profile
Ji-Won Kim is currently the Chief Executive Officer of Aju IB Investment Co., Ltd.
(Private Equity) and also holds the position of Director at SL VaxiGen, Inc. Prior to this, he was the Chief Executive Officer & Director at AJU IB Investment Co., Ltd.
starting from 1999.
Mr. Kim completed his undergraduate degree from Yonsei University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 08/05/2024 | 131,755 ( 0.11% ) | 272 166 $ | 30/04/2024 |
Ji-Won Kim active positions
| Companies | Position | Start |
|---|---|---|
| AJU IB INVESTMENT CO., LTD. | Chief Executive Officer | 01/01/1999 |
Aju IB Investment Co., Ltd. (Private Equity)
 Aju IB Investment Co., Ltd. (Private Equity) Investment ManagersFinance Aju IB Investment Co., Ltd. (Aju IB) is the venture capital subsidiary of AJU Capital Co., Ltd founded in 1974 by Korea Technology Development Corp. The firm is headquartered in Seoul, Korea. | Chief Executive Officer | - |
SL VaxiGen, Inc.
 SL VaxiGen, Inc. Pharmaceuticals: MajorHealth Technology SL VaxiGen, Inc. operates as research and development company which engages in developing vaccine therapeutics based on complementary platforms for saving lives. The company was founded on March 3, 2017 and is headquartered in Seongnam, South Korea. | Director/Board Member | - |
Training of Ji-Won Kim
| Yonsei University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| AJU IB INVESTMENT CO., LTD. | Finance |
| Private companies | 2 |
|---|---|
Aju IB Investment Co., Ltd. (Private Equity)
Aju IB Investment Co., Ltd. (Private Equity) Investment ManagersFinance Aju IB Investment Co., Ltd. (Aju IB) is the venture capital subsidiary of AJU Capital Co., Ltd founded in 1974 by Korea Technology Development Corp. The firm is headquartered in Seoul, Korea. | Finance |
SL VaxiGen, Inc.
SL VaxiGen, Inc. Pharmaceuticals: MajorHealth Technology SL VaxiGen, Inc. operates as research and development company which engages in developing vaccine therapeutics based on complementary platforms for saving lives. The company was founded on March 3, 2017 and is headquartered in Seongnam, South Korea. | Health Technology |
- Stock Market
- Insiders
- Ji-Won Kim
